Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients | Zendy

Oriol Manuel | Zendy; Manuel Pascual | Zendy; Katja Höschler | Zendy; Stefano Giulieri | Zendy; Daniela Alves | Zendy; Kim Ellefsen | Zendy; PierreAlexandre Bart | Zendy; Jean-Pierre Venetz | Zendy; Thierry Calandra | Zendy; Matthias Cavassini | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients

Author(s) -

Oriol Manuel,

Manuel Pascual,

Katja Höschler,

Stefano Giulieri,

Daniela Alves,

Kim Ellefsen,

PierreAlexandre Bart,

Jean-Pierre Venetz,

Thierry Calandra,

Matthias Cavassini

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciq104

Subject(s) - medicine , virology , influenza vaccine , immunology , h1n1 influenza , vaccination , covid-19 , infectious disease (medical specialty) , disease

Few data are available regarding the immunogenicity and safety of the pandemic influenza vaccine in immunocompromised patients. We evaluated the humoral response to the influenza A H1N1/09 vaccine in solid-organ transplant (SOT) recipients, in patients with human immunodeficiency virus (HIV) infection, and in healthy individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research